A Single-Arm, Open-Label, Pilot Study of the JAK1 Selective Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome in T-Cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

被引：7

作者：

Abboud, Ramzi ^{[1
]}

Gao, Feng ^{[2
]}

Rettig, Michael P. ^{[1
]}

Eisele, Jeremy ^{[1
]}

Gehrs, Leah ^{[1
]}

Wallace, Nichols ^{[1
]}

Abboud, Camille, Sr. ^{[3
]}

Westervelt, Peter ^{[4
]}

Uy, Geoffrey L. ^{[1
]}

Cashen, Amanda F. ^{[4
]}

Christopher, Matt ^{[1
]}

Ghobadi, Armin ^{[1
]}

Jacoby, Meagan A. ^{[1
]}

Pusic, Iskra ^{[1
]}

Stockerl-Goldstein, Keith E. ^{[1
]}

DiPersio, John F. ^{[1
]}

Schroeder, Mark A. ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Dept Med, BMT & Leukemia Program, St Louis, MO 63110 USA

[2] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA

[3] Washington Univ, Div Oncol, St Louis, MO 63110 USA

[4] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA

来源：

关键词：

D O I：

10.1182/blood-2021-144591

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

100

引用

页数：4